Navigation Links
Global Markets and Technologies for Optical Coherence Tomography (OCT)
Date:5/21/2013

D-OCT BY END USERS, THROUGH

2017 ($ MILLIONS) 70

FIGURE 18 GLOBAL REVENUE OF PS-OCT AND TD-OCT BY END USERS, 2010-2017

($ MILLIONS) 72

PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY 72

Market Revenue 73

TABLE 31 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN THE

PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES, THROUGH 2017 ($

MILLIONS)

73

FIGURE 19 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN THE

PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES, 2010-2017 ($ MILLIONS) 73

ENVIRONMENTAL SCIENCE INDUSTRY 74

Market Revenue 74

TABLE 32 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN THE ENVIRONMENTAL

SCIENCES INDUSTRY, THROUGH 2017 ($ MILLIONS) 75

FIGURE 20 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN THE

ENVIRONMENTAL SCIENCES INDUSTRY, 2010-2017 ($ MILLIONS) 75

FOOD AND BEVERAGE INDUSTRY 76

Market Revenue 76

TABLE 33 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN THE FOOD AND

BEVERAGE INDUSTRY, THROUGH 2017 ($ MILLIONS) 76

FIGURE 21 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN THE FOOD AND

BEVERAGE INDUSTRY, 2010-2017 ($ MILLIONS) 77

OTHER INDUSTRIES 77

Market Revenue 77

TABLE 34 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN OTHER INDUSTRIES,

THROUGH 2017 ($ MILLIONS) 78

FIGURE 22 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN OTHER INDUSTRIES,

2010-2017 ($ MILLIONS) 78

MARKET SHARE 78

TABLE 35 MARKET SHARE OF TD-OCT AND PS-OCT BY APPLICATION, 2011 (%) 79

FIGURE 23 MARKET SHARE OF TD-OCT AND PS-OCT BY APPLICATION, 2011 (%) 79

INDUSTRY STRUCTURE 79

TIME DOMAIN OPTICAL COHERENCE TOMOGRAPHY 79

Market Leaders 79

TABLE 36 MAJOR MANUFACTURERS IN TD-OCT, 2011 80

Market Share 80

TABLE 37 MARKET SHARE FOR MANUFACTURERS IN TD-OCT, 2011 (%) 80

FIGURE 24 MARKET SHARE FOR MANUFACTURERS IN TD-OCT, 2011 (%) 80

POLARIZATION SENSITIVE OPTICAL COHEREN
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
2. TRACE Releases 2012 Global Enforcement Report
3. Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
4. PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems
5. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City
6. HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
7. Amgen To Present At The UBS Global Life Sciences Conference
8. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
9. The Rockley Group and Content Rules Ink Deal to Extend Global Reach
10. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
11. Global Information Online Market Research Portal Provides Complimentary Sample Service for Customers to Preview Reports by Global Industry Analysts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014   , 2014 Second Quarter ... prior year , Overall organic growth was 4% for same ... products; Bausch + Lomb grew 12% , 2014 Second ... 43% , 2014 Second Quarter GAAP Operating Cash Flow ... , Highlights of the Second Quarter , Launched 17 new ...
(Date:7/31/2014)... PARK, N.C. , July 31, 2014 ... Miami facilities to meet the clinical trial ... .  The newly expanded facility will continue to ... consolidation of shipments to and from the region, and ... its newest location, Marken will combine its office and ...
(Date:7/31/2014)... , July 31, 2014 Auxilium ... a specialty biopharmaceutical company, today announced that the ... payment from its partner Asahi Kasei Pharma Corporation ... the successful submission of a regulatory application to ... for XIAFLEX ® (collagenase clostridium histolyticum) for ...
Breaking Medicine Technology:Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 3Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 4Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 5Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 6Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 7Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 8Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 9Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 10Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 11Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 12Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 13Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 14Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 15Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 16Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 17Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 18Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 19Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 20Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 21Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 22Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 23Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 24Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 25Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 26Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 27Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 28Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 29Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 30Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 31Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 32Marken Expands Miami Regional Logistics Center 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4
... , BUDAPEST, Hungary , ... Pfizer Globally Licenses ChemAxon,s Platform For Markush Structure,Searching And Enumeration ... of cheminformatics software for the life,sciences industry has entered into ... functionality for global,development and deployment within Pfizer,s global R&D facilities. ...
... , , , ... The U.S. Food and Drug Administration today approved Ampyra (dalfampridine) ... sclerosis (MS). In clinical trials, patients treated with Ampyra had ... (placebo). This is the first drug approved for this use. ...
Cached Medicine Technology:FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis 2
(Date:7/31/2014)... Care Communications, Inc., (CARE) a national health care ... Elite Award for “Recruitment, Selection and Orientation” from the ... awards presented as part of “Chicago’s 101 ... awards competition. This marks the seventh consecutive year Care ... CARE has also been chosen as a national winner ...
(Date:7/31/2014)... 31, 2014 Daily Gossip reveals in its ... sufferers discover some breakthrough weight loss tips. , The ... and recommendations are very simple to implement. Users don’t have ... with no need to start counting calories. , The ... in fact created a 12 weeks weight loss program to ...
(Date:7/31/2014)... In its latest blog post, Best ... having family close by during a stay in rehab can ... is successful, is looking at 10 tips to help drug ... recovery is a lifelong process, and one that former addicts ... without compromise,” commented Best Drug Rehabilitation’s CEO Per Wickstrom ...
(Date:7/31/2014)... 31, 2014 The study, The ... in Medicare episode of care payments for four clinical ... major joint replacements (hips and knees). Using the ... Payments for Care Improvement program, the study examines these ... regions in the country. , “Our study reaffirms that, ...
(Date:7/30/2014)... 30, 2014 The Mesothelioma ... Penn's Abramson Cancer Center, will host a regional ... experts in the field of mesothelioma. September 26 marks ... is open to the public, and specifically aimed at ... who have been exposed to asbestos. , The conference ...
Breaking Medicine News(10 mins):Health News:Care Communications, Inc. Named an Elite Award Winner Among Top Chicago Employers 2Health News:New Best Drug Rehabilitation Blog Posts Looks at 10 Tips for Coping After Drug or Alcohol Rehab 2Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 2Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 3Health News:September Events: Regional Conference on Mesothelioma in Philadelphia 2Health News:September Events: Regional Conference on Mesothelioma in Philadelphia 3
... in five Americans,suffers from the pain of arthritis. The ... the year 2030, 67 million people in the,U.S. will ... million.,Arthritis can be a painful, life-impacting condition, but its ... such as walking, is crucial in preventing and,managing the ...
... Press announces the,release of a new book -- ... to help older people understand and proactively address ... Dr. Heather D.,Hadjistavropoulos and their contributors, this softcover ... and,simple instructions for managing persistent pain., "With ...
... More, a,national non-profit dedicated to improving the lives ... season. Invisimomibility is a,chronic, pervasive condition in which ... inability to successfully fulfill one,s,caregiving, civic and paid ... and economic risk., For decades, the unpaid ...
... 25, 2008) -- Heart failure patients at NewYork-Presbyterian Hospital/Columbia ... implanted with the HeartMate II LVAS (Left Ventricular Assist ... hearts pump blood -- that has now received approval ... use as bridge to transplantation. As part of clinical ...
... WebMD Health Corp. (Nasdaq:,WBMD) and HLTH Corporation (Nasdaq: ... scheduled to participate at the Third Annual Needham & ... 2008 at 8:00 am ET., Investors, analysts and ... audio broadcast of the presentation over the Internet. The ...
... in,Brachioplasty (arm lift) techniques will be discussed by leading ... Aesthetic Plastic Surgery,(ASAPS) being held at the San Diego ... Arm: A Treatment Algorithm" will be moderated by,Daniel Morello, ... discuss,traditional Brachioplasty; Felmont Eaves, MD, who will discuss the,procedure ...
Cached Medicine News:Health News:GET UP AND MOVE! May is Arthritis Awareness Month - The Perfect Time to Learn the Importance of Staying Active 2Health News:New Book Helps Older Adults Manage Chronic Pain 2Health News:Mothers & More Fights to End Invisimomibility 2Health News:FDA approves HeartMate II mechanical heart pump for heart-failure patients 2Health News:Current Trends in Arm Lift Surgery 2Health News:Current Trends in Arm Lift Surgery 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: